ArticleMethods in molecular biology (Clifton, N.J.)2026
T Cell Antigen Discovery Using Cell-Based Epitope Libraries.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hybrid Insulin Peptides as Antigens and Tolerogens for Pathogenic T Cells in Autoimmune Diabetes.Immunological reviews · 2026Review
- Coincident epithelial signals restrain commensal-specific CD8αβbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
T cells carry out their functions by specifically recognizing antigens through their T cell receptors (TCRs), making the identification of TCR specificities crucial for understanding health and disease. Over the past decade, several antigen discovery methods have been developed to deconvolute TCRs. Our laboratory has established a cell-based antigen discovery platform based on chimeric receptors termed "SABRs" (Signaling and Antigen-presenting Bifunctional Receptors). SABRs are extracellular peptide-MHC complexes fused to intracellular signaling domains. SABRs present a covalently linked epitope to T cells and induce a readable signal upon their recognition. Moreover, large epitope libraries in SABRs can be constructed to screen the cognate epitopes of a given TCR. The modularity and continued refinement of SABRs allow antigen discovery for CD8+ and CD4+ T cells. In this chapter, we provide an overview of the SABR platform, followed by a detailed description of the steps involved in the generation of SABR libraries and performing SABR screens to deconvolute TCR specificities.
Indexed as
Identifiers
41269545What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.